Aurigene Oncology is a leading clinical-stage biotechnology company focused on developing innovative therapies in the field of oncology and autoimmune diseases. Headquartered in India, Aurigene is a fully integrated subsidiary of Dr. Reddy’s Laboratories. The company is committed to advancing precision medicine and discovering novel small molecules and biologics aimed at addressing unmet medical needs in cancer treatment.
Requirement Details:
WE ARE HIRING!
RESEARCH ASSOCIATE – CGT R&D – CELL THERAPY
DESIRED PROFILE:
M.Sc/M.Tech in Biotechnology with 3-8 years of relevant experience in academia and/or industry.
LOCATION: Bangalore
ROLES AND RESPONSIBILITIES:
• Candidate will be expected to have worked with primary cells and cell lines in immunology or immuno-oncology context. Prior experience working in development and validation of cell and gene therapy products will be preferred.
• Must be well-versed in flow cytometry, sorting, cell-based assay development, immunological assays, real-time PCR, and microbiological assays.
• Should be able to effectively communicate and work closely in a highly matrixed team environment to advance company’s cell therapy pipeline.
• Should be able to closely coordinate and show active participation working with internal functions like manufacturing, quality assurance, clinical development, supply chain management as well as with external collaborators for development of a product.
• Expected to exhibit strict adherence to project timelines while preserving integrity, accuracy, safety, and quality.
• Must be involved in preparation and review of SOPs, protocols, reports, regulatory documents, pertaining to program requirement.
• Understand systems and processes pertaining to sterile practices, work ethics, safety, health, and environment.
MANDATORY SKILLS REQUIRED:
• Multi-colour Flow cytometry.
• Cell Based Assays – Immunological and Immuno-oncological.
• Stable cell line generation.
• Molecular biology techniques like PCR, gPCR, cloning.
Interested candidates may send their resume to : [email protected]
